rs147240777

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_015474.4(SAMHD1):​c.77C>T​(p.Pro26Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00045 in 1,614,204 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0023 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

SAMHD1
NM_015474.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: -0.888
Variant links:
Genes affected
SAMHD1 (HGNC:15925): (SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1) This gene may play a role in regulation of the innate immune response. The encoded protein is upregulated in response to viral infection and may be involved in mediation of tumor necrosis factor-alpha proinflammatory responses. Mutations in this gene have been associated with Aicardi-Goutieres syndrome. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0048927367).
BP6
Variant 20-36951567-G-A is Benign according to our data. Variant chr20-36951567-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 338350.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=1}. Variant chr20-36951567-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00234 (357/152376) while in subpopulation AFR AF= 0.00827 (344/41590). AF 95% confidence interval is 0.00755. There are 1 homozygotes in gnomad4. There are 165 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SAMHD1NM_015474.4 linkuse as main transcriptc.77C>T p.Pro26Leu missense_variant 1/16 ENST00000646673.2 NP_056289.2
SAMHD1NM_001363729.2 linkuse as main transcriptc.77C>T p.Pro26Leu missense_variant 1/15 NP_001350658.1
SAMHD1NM_001363733.2 linkuse as main transcriptc.77C>T p.Pro26Leu missense_variant 1/16 NP_001350662.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SAMHD1ENST00000646673.2 linkuse as main transcriptc.77C>T p.Pro26Leu missense_variant 1/16 NM_015474.4 ENSP00000493536 P1Q9Y3Z3-1

Frequencies

GnomAD3 genomes
AF:
0.00234
AC:
357
AN:
152260
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00830
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.000593
AC:
149
AN:
251282
Hom.:
1
AF XY:
0.000449
AC XY:
61
AN XY:
135848
show subpopulations
Gnomad AFR exome
AF:
0.00831
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000252
AC:
369
AN:
1461828
Hom.:
0
Cov.:
31
AF XY:
0.000204
AC XY:
148
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.00881
Gnomad4 AMR exome
AF:
0.000514
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.000729
GnomAD4 genome
AF:
0.00234
AC:
357
AN:
152376
Hom.:
1
Cov.:
32
AF XY:
0.00221
AC XY:
165
AN XY:
74522
show subpopulations
Gnomad4 AFR
AF:
0.00827
Gnomad4 AMR
AF:
0.000719
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.000392
Hom.:
1
Bravo
AF:
0.00268
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000700
AC:
85

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Aicardi-Goutieres syndrome 5 Benign:2
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsApr 11, 2018- -
Aicardi Goutieres syndrome Benign:1
Likely benign, no assertion criteria providedclinical testingNatera, Inc.Nov 11, 2019- -
Chilblain lupus 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
7.9
DANN
Benign
0.89
DEOGEN2
Benign
0.084
T;.;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.096
N
LIST_S2
Benign
0.81
.;T;T;T
M_CAP
Uncertain
0.099
D
MetaRNN
Benign
0.0049
T;T;T;T
MetaSVM
Benign
-0.34
T
MutationAssessor
Benign
1.7
L;L;.;L
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-2.0
.;N;.;.
REVEL
Benign
0.14
Sift
Uncertain
0.023
.;D;.;.
Sift4G
Benign
0.11
.;T;.;.
Polyphen
0.0030
B;.;.;.
Vest4
0.14
MVP
0.75
MPC
0.62
ClinPred
0.0093
T
GERP RS
-3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.069
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147240777; hg19: chr20-35579970; API